Champlain Investment Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Champlain Investment Partners's RGEN Position: Q2 2026 in Review
Champlain Investment Partners reduced its Repligen (RGEN) stake by 54% in Q2 2026, selling an estimated $46.1M and leaving 318,955 shares worth $43.5M. The position accounts for 1.12% of the portfolio, ranked #21.
Champlain Investment Partners first reported a position in RGEN in Q3 2022 and has held it in 16 quarters since. The position peaked at $222M in Q4 2024. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Champlain Investment Partners held 318,955 shares of Repligen worth $43.5M as of Q2 2026.
- Champlain Investment Partners sold 374,900 Repligen shares in Q2 2026, an estimated $46.1M.
- Repligen made up 1.12% of Champlain Investment Partners's portfolio in Q2 2026, its #21 holding.
- Champlain Investment Partners first reported a position in Repligen in Q3 2022 and has held it in 16 quarters since.
- Champlain Investment Partners's Repligen position peaked at $222M in Q4 2024.
- 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.